| 摘要 |
<p>The present invention is directed to a compound of formula (I), or a pharmaceutically acceptable salt, solvate hydrate or stereoisomer thereof, which is useful in treating or preventing disorders mediated by a peroxisome proliferator activated receptor (PPAR) such as syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to syndrome X and cardiovascular diseases.</p> |
| 申请人 |
ELI LILLY AND COMPANY;CANADA, EMILY, JANE;GOSSETT, LYNN, STACY;MANTELO, NATHAN, BRYAN;SHI, QING;WANG, MINMIN;WARSHAWSKY, ALAN, M.;XU, YANPING |
发明人 |
CANADA, EMILY, JANE;GOSSETT, LYNN, STACY;MANTELO, NATHAN, BRYAN;SHI, QING;WANG, MINMIN;WARSHAWSKY, ALAN, M.;XU, YANPING |
